Buy Soliqua Solostar Pens Online

Buy Soliqua Solostar Pens online with a valid prescription and compare current listed pricing, the 100/33 pen presentation, pack details, and key safety basics before checkout.

Use the selected listing to match your prescribed product, strength, and quantity before you order, especially if you are comparing US delivery from Canada. This PDP also highlights storage, handling, and safety points that matter for a refrigerated injectable pen.

Soliqua Solostar Pens Price and Available Options

Start with the current listed price on the product page, then check the selected presentation. Soliqua 100/33 price comparisons should account for the pen concentration, pack count, total mL, and whether a listing is for a single device or a multi-pen carton.

This listing is for Soliqua 100/33 in SoloStar prefilled pens, a combination of insulin glargine and lixisenatide. The page title indicates 100 units/mL and 33 mcg/mL, with a 5 x 3 mL presentation. That means the total carton contents differ from the amount delivered with any single use, so the pack size should be matched to your written order rather than estimated from daily use.

If you are comparing Soliqua without insurance, separate the cash-pay amount from any plan, claim, or reimbursement question. The Soliqua cash price shown on a product page can differ from what a health plan may recognize, and different presentations may be listed separately. Look at the selected strength, quantity, shipping or handling charges, and any checkout fields before deciding whether the displayed option matches your order details.

Customers comparing diabetes products can also browse the Insulin Medications collection to see how insulin-only products are organized. Use category browsing for comparison, not as a reason to switch from a prescribed combination product.

Quick tip: Match the pen name, strength, and pack count before comparing totals.

How to Buy Soliqua Solostar Pens Online

To order Soliqua online, choose the correct product listing, confirm the 100/33 pen details, and provide the required order information at checkout. Keep your prescriber information available in case the listed product, quantity, or instructions need confirmation.

Prescription details may be verified with your prescriber when needed. Supporting documents may also be requested for some orders, especially when the selected product, quantity, or instructions need clarification before the order moves forward.

Before you submit checkout details, compare the product name on the page with the name on your written order. Soliqua Solostar Pens Canada search results may show different carton sizes or country-specific listings, so the useful check is the actual presentation on this PDP: SoloStar pen, insulin glargine plus lixisenatide, and the listed 100/33 concentration.

For a refrigerated injectable, logistics also matter. Make sure the address, contact details, and timing considerations are accurate for a temperature-sensitive product. Do not rely on a previous insulin order if your clinician changed the prescribed combination, dose range, or pen type.

Product Details That Affect Selection

Soliqua is supplied as a prefilled pen injector. It combines insulin glargine, a long-acting basal insulin, with lixisenatide, a glucagon-like peptide-1 receptor agonist (GLP-1 medicine) that helps improve blood sugar control after meals. The combination design is why the listing should be checked more carefully than a standard basal insulin pen.

The Soliqua insulin pen uses dose steps, but the number displayed on the pen is not the same as a simple mL measurement. It reflects the combination product design. Do not convert the strength or compare it to a vial without clinician or pharmacist guidance.

Needle compatibility and injection technique are practical order checks. If pen needles are listed separately, confirm whether you already have the correct type. General device steps are covered in the Insulin Pen Guide, while your own technique should follow the training provided by your care team.

Do not share a Soliqua prefilled pen, even if the needle is changed. Shared pens can transmit infection. The pen should also be inspected before use; do not use it if the solution appears cloudy, colored, or contains particles.

What This Combination Pen Is Used For

Soliqua 100/33 is used with diet and exercise to improve glycemic control in adults with type 2 diabetes. It is a prescription combination of insulin glargine and lixisenatide, so it is not the same as ordering basal insulin alone or a stand-alone GLP-1 medicine.

The treatment is not for type 1 diabetes or diabetic ketoacidosis. It also has not been studied in people with pancreatitis history in the same way as some other medicines, and severe stomach-emptying problems can make GLP-1 therapy unsuitable. These points should be part of the safety check before starting or continuing the product.

If you want to understand the non-insulin component class, the GLP-1 Agonists collection shows related medicine types. Soliqua remains a combination pen, so category browsing should not replace the product name on your order.

A focused Soliqua SoloStar Pen Support resource can also help with plain-language background on the dual-action design. Use it to prepare questions, not to change your prescribed routine.

Storage, Handling, and Travel Basics

Soliqua Solostar Pens are temperature-sensitive. Unused pens are generally stored in a refrigerator at 2°C to 8°C and should not be frozen. Keep them away from direct heat and light, and do not use any pen that has been frozen.

After first use, the pen is typically kept at room temperature below 30°C and discarded after 28 days, even if some medicine remains. Do not store the pen with a needle attached. Removing the needle after each injection helps reduce leakage, air entry, and contamination risk.

When traveling, keep the pen in a temperature-protected case and avoid placing it directly against ice packs. Airport screening, long car rides, and hotel refrigerators can expose medicine to temperature swings. Carry your prescription details and supplies together so the product can be identified if asked.

For shipping and handling, refrigerated products may require insulated packing and express, cold-chain shipping when appropriate. This supports temperature control during transit but does not remove the need to inspect the package and product condition when it arrives.

Why it matters: Temperature damage can affect a pen before the carton looks unusual.

Safety Information Before Buying

Soliqua can cause low blood sugar, especially when used with other glucose-lowering medicines or if meals, activity, or dosing routines change. Symptoms may include shakiness, sweating, confusion, fast heartbeat, hunger, or dizziness. Severe hypoglycemia can require urgent treatment.

This medicine is contraindicated during episodes of hypoglycemia and in people with serious hypersensitivity to insulin glargine, lixisenatide, or any ingredient in the product. Allergic reactions can include rash, swelling, trouble breathing, or severe dizziness. Seek urgent help if symptoms suggest a serious reaction.

Common side effects can include nausea, vomiting, diarrhea, headache, and injection-site reactions. Gastrointestinal effects may be more noticeable when therapy begins or when the body is adjusting. Ongoing vomiting or diarrhea can raise dehydration risk and may affect kidney function.

Pancreatitis has been reported with GLP-1 receptor agonists. Severe abdominal pain that may spread to the back, especially with vomiting, needs prompt clinical attention. Gallbladder problems have also been reported with this medicine class, and symptoms such as right upper abdominal pain, fever, or yellowing skin should not be ignored.

Because Soliqua includes insulin, low potassium can occur, especially when combined with medicines that lower potassium. Fluid retention and heart failure can also be a concern when insulin is used with thiazolidinediones, a class that includes pioglitazone and rosiglitazone. These risks are part of the product safety discussion before ordering.

Interactions and Monitoring Checks

Give your clinician and pharmacist a current list of diabetes medicines, heart medicines, diuretics, steroids, antibiotics, supplements, and over-the-counter products. Some medicines can raise blood sugar, while others increase the chance of hypoglycemia. Beta blockers may also make some low-blood-sugar symptoms harder to notice.

Soliqua is not usually evaluated as an add-on to prandial, or mealtime, insulin. Combining therapies without a clear plan can increase side effect risk or make glucose patterns harder to interpret. Any change involving basal insulin, mealtime insulin, sulfonylureas, or GLP-1 therapy should be directed by the prescribing clinician.

Monitoring usually includes blood glucose checks and periodic A1C testing. Your clinician may also consider kidney function, hydration status, weight changes, gastrointestinal tolerance, and injection-site problems. If readings become unusually high or low, record the timing, meals, activity, and other medicines before contacting your care team.

Ask before using this pen if you are pregnant, planning pregnancy, breastfeeding, have severe stomach problems, have kidney disease, or have a history of pancreatitis. These factors may affect whether the selected product remains appropriate.

Compare Related Diabetes Options

Soliqua is one option among diabetes injectables, but it should not be compared only by pen appearance. It combines a basal insulin with a GLP-1 medicine. A basal insulin-only product, such as Lantus SoloStar Pens, has a different role and does not contain lixisenatide.

Another combination injectable, Xultophy Prefilled Pen, contains different active ingredients. That difference matters for dosing, side effects, contraindications, and storage details. Product substitutions should come from your prescriber, not from matching pen format alone.

Customers comparing broader basal insulin choices can use the Long-Acting Insulin category for navigation. For Soliqua, the key decision remains whether the exact combination pen, strength, quantity, and handling needs match your written order.

Authoritative Sources

Official prescribing information supports the uses, contraindications, warnings, storage, and handling details summarized here: SOLIQUA 100/33 Prescribing Information.

Product labeling should be checked whenever there is a question about storage limits, pen use, severe side effects, or whether another diabetes medicine can be used with this combination product.

This content is for informational purposes only and is not a substitute for professional medical advice.